Driehaus Capital Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Driehaus Capital Management’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,211,728	Closed	-$23.3M	–	544
2020 Q4	$23.3M	Buy	1,211,728 +40,193	+3%	+$620K	0.38%	83
2020 Q3	$15.7M	Buy	1,171,535 +385,622	+49%	+$10.9M	0.32%	91
2020 Q2	$33.3M	Buy	785,913 +81,325	+12%	+$2.63M	0.81%	22
2020 Q1	$19.5M	Buy	704,588 +40,129	+6%	+$1.17M	0.65%	37
2019 Q4	$21.6M	Buy	664,459 +138,737	+26%	+$4.3M	0.57%	45
2019 Q3	$13.7M	Buy	525,722 +1,889	+0.4%	+$63.2K	0.45%	61
2019 Q2	$19.2M	Buy	523,833 +356,417	+213%	+$8.54M	0.6%	45
2019 Q1	$3.7M	Buy	+167,416	New	+$2.93M	0.14%	166

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Driehaus Capital Management's ODT Position: Q1 2021 in Review

Driehaus Capital Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 1,211,728 shares — an estimated $23.3M sold.

Driehaus Capital Management first reported a position in ODT in Q1 2019 and held it in 8 quarters. The position peaked at $33.3M in Q2 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

Driehaus Capital Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Driehaus Capital Management sold 1,211,728 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $23.3M.
Driehaus Capital Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2019 and held it in 8 quarters.
Driehaus Capital Management's Odonate Therapeutics, Inc. Common Stock position peaked at $33.3M in Q2 2020.
83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Driehaus Capital Management's 13F filing for Q1 2021, filed 17 May 2021.